How BMS is Doing RBM (Risk-Based Monitoring)

May 14, 2014
Guest Blogger

Pharmaceutical Executive

At this year’s Bio IT World Conference, Thomas Verish, Group Director of Data Operations Services at Bristol-Myers Squibb,

At this year’s Bio IT World Conference, Thomas Verish, Group Director of Data Operations Services at Bristol-Myers Squibb, elaborated on BMS’s risk-based monitoring (RBM) pilot, and how they are leveraging data, statistical analysis and personnel to execute RBM.

In this Applied Clinical Trials blog, Moe Alsumidale outlines the BMS’s RBM infrastructure.

Related Content:

News